|
|
cloacal septation
|
GO:0060197 |
1 |
1.000
|
|
|
|
hair follicle morphogenesis
|
GO:0031069 |
2 |
1.000
|
Human |
|
|
keratinization
|
GO:0031424 |
2 |
1.000
|
Human |
|
|
epidermis morphogenesis
|
GO:0048730 |
3 |
0.998
|
Human |
|
|
hair cycle
|
GO:0042633 |
28 |
0.992
|
Human |
|
|
oxidative stress induced premature senescence
|
GO:0090403 |
3 |
0.979
|
|
|
|
leukotriene a4 metabolic process
|
GO:1901751 |
1 |
0.957
|
|
|
|
water homeostasis
|
GO:0030104 |
14 |
0.954
|
|
|
|
keratinocyte differentiation
|
GO:0030216 |
36 |
0.953
|
Human |
|
|
positive regulation of keratinocyte proliferation
|
GO:0010838 |
4 |
0.941
|
|
|
|
skin development
|
GO:0043588 |
76 |
0.930
|
Human |
|
|
golgi to plasma membrane cftr protein transport
|
GO:0043000 |
1 |
0.920
|
|
|
|
hepoxilin metabolic process
|
GO:0051121 |
1 |
0.920
|
|
|
|
intermediate filament based process
|
GO:0045103 |
17 |
0.903
|
Human |
|
|
hepoxilin biosynthetic process
|
GO:0051122 |
1 |
0.892
|
|
|
|
regulation of cardiac muscle cell proliferation
|
GO:0060043 |
4 |
0.863
|
|
|
|
multicellular organismal water homeostasis
|
GO:0050891 |
14 |
0.841
|
|
|
|
lipoxygenase pathway
|
GO:0019372 |
4 |
0.838
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
141 |
0.838
|
Human |
|
|
epithelium development
|
GO:0060429 |
227 |
0.795
|
Human |
|
|
intermediate filament cytoskeleton organization
|
GO:0045104 |
17 |
0.785
|
Human |
|
|
epidermal cell differentiation
|
GO:0009913 |
45 |
0.767
|
Human |
|
|
epithelial cell migration
|
GO:0010631 |
119 |
0.747
|
Human |
|
|
cardiac muscle cell contraction
|
GO:0086003 |
4 |
0.736
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
73 |
0.704
|
|
|
|
epidermis development
|
GO:0008544 |
59 |
0.694
|
Human |
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.672
|
|
|
|
positive regulation of fibroblast apoptotic process
|
GO:2000271 |
6 |
0.647
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
78 |
0.610
|
|
|
|
cloaca development
|
GO:0035844 |
1 |
0.583
|
|
|
|
intermediate filament organization
|
GO:0045109 |
10 |
0.547
|
Human |
|
|
prostate gland morphogenesis
|
GO:0060512 |
1 |
0.535
|
|
|
|
skin morphogenesis
|
GO:0043589 |
6 |
0.534
|
Human |
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.527
|
|
|
|
negative regulation of epidermis development
|
GO:0045683 |
5 |
0.524
|
|
|
|
establishment of skin barrier
|
GO:0061436 |
5 |
0.518
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.477
|
|
|
|
negative regulation of keratinocyte differentiation
|
GO:0045617 |
3 |
0.449
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.446
|
|
|
|
catagen
|
GO:0042637 |
3 |
0.443
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
26 |
0.430
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
12 |
0.402
|
|
|
|
wound healing
|
GO:0042060 |
115 |
0.397
|
Zebrafish |
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.370
|
|
|
|
establishment of planar polarity
|
GO:0001736 |
3 |
0.361
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
125 |
0.360
|
|
|
|
negative regulation of epidermal cell differentiation
|
GO:0045605 |
4 |
0.353
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
180 |
0.322
|
|
|
|
molting cycle
|
GO:0042303 |
28 |
0.319
|
Human |
|
|
organ morphogenesis
|
GO:0009887 |
147 |
0.315
|
Human |
|
|
regulation of epithelial cell differentiation
|
GO:0030856 |
24 |
0.315
|
|
|
|
regulation of heart growth
|
GO:0060420 |
4 |
0.308
|
|
|
|
regulation of cell motility
|
GO:2000145 |
299 |
0.296
|
|
|
|
hair cycle process
|
GO:0022405 |
12 |
0.293
|
Human |
|
|
regulation of locomotion
|
GO:0040012 |
329 |
0.286
|
|
|
|
positive regulation of mesenchymal cell proliferation
|
GO:0002053 |
2 |
0.281
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
128 |
0.278
|
Human |
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
4 |
0.272
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
170 |
0.272
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.272
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
127 |
0.267
|
|
|
|
establishment of tissue polarity
|
GO:0007164 |
3 |
0.265
|
|
|
|
negative regulation of heart growth
|
GO:0061117 |
2 |
0.265
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
100 |
0.264
|
Human |
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.259
|
|
|
|
regulation of water loss via skin
|
GO:0033561 |
5 |
0.252
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
99 |
0.249
|
|
|
|
organ formation
|
GO:0048645 |
3 |
0.247
|
|
|
|
regulation of cell migration
|
GO:0030334 |
289 |
0.243
|
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.241
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.239
|
|
|
|
negative regulation of striated muscle tissue development
|
GO:0045843 |
11 |
0.239
|
|
|
|
regulation of cardiac muscle tissue growth
|
GO:0055021 |
4 |
0.236
|
|
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.232
|
|
|
|
regulation of endothelial cell differentiation
|
GO:0045601 |
4 |
0.232
|
|
|
|
membrane organization
|
GO:0061024 |
292 |
0.221
|
|
|
|
circulatory system process
|
GO:0003013 |
113 |
0.220
|
|
|
|
biological adhesion
|
GO:0022610 |
331 |
0.214
|
|
|
|
regulation of cell division
|
GO:0051302 |
116 |
0.205
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
95 |
0.203
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.203
|
|
|
|
actin filament based process
|
GO:0030029 |
224 |
0.203
|
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.200
|
|
|
|
lipoxin b4 biosynthetic process
|
GO:2001306 |
1 |
0.197
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.194
|
|
|
|
odontogenesis
|
GO:0042476 |
25 |
0.193
|
|
|
|
regulation of cell growth
|
GO:0001558 |
135 |
0.193
|
|
|
|
response to ionizing radiation
|
GO:0010212 |
65 |
0.186
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.183
|
|
|
|
endothelial cell migration
|
GO:0043542 |
86 |
0.182
|
|
|
|
cardiac muscle cell action potential
|
GO:0086001 |
23 |
0.181
|
|
|
|
response to metal ion
|
GO:0010038 |
84 |
0.181
|
|
|
|
leukotriene metabolic process
|
GO:0006691 |
10 |
0.179
|
|
|
|
tissue morphogenesis
|
GO:0048729 |
96 |
0.178
|
Human |
|
|
seminal clot liquefaction
|
GO:0070684 |
1 |
0.178
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
180 |
0.172
|
|
|
|
regulation of cardiac muscle contraction
|
GO:0055117 |
33 |
0.172
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.171
|
|
|
|
positive regulation of intrinsic apoptotic signaling pathway
|
GO:2001244 |
28 |
0.168
|
|
|
|
keratinocyte proliferation
|
GO:0043616 |
17 |
0.166
|
Human |
|
|
keratinocyte migration
|
GO:0051546 |
6 |
0.165
|
Human |
|
|
negative regulation of cardiac muscle cell proliferation
|
GO:0060044 |
2 |
0.164
|
|
|
|
establishment of protein localization to plasma membrane
|
GO:0090002 |
68 |
0.159
|
|
|
|
linoleic acid metabolic process
|
GO:0043651 |
4 |
0.155
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
102 |
0.154
|
|
|
|
morphogenesis of an epithelium
|
GO:0002009 |
60 |
0.152
|
Human |
|
|
protein localization to membrane
|
GO:0072657 |
160 |
0.150
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.149
|
|
|
|
system process
|
GO:0003008 |
349 |
0.149
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
405 |
0.148
|
|
|
|
cell division
|
GO:0051301 |
168 |
0.144
|
|
|
|
regulation of protein oligomerization
|
GO:0032459 |
26 |
0.143
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.142
|
|
|
|
positive regulation of osteoblast differentiation
|
GO:0045669 |
23 |
0.142
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.140
|
|
|
|
keratinocyte activation
|
GO:0032980 |
1 |
0.140
|
Human |
|
|
intracellular protein transport
|
GO:0006886 |
270 |
0.140
|
|
|
|
regulation of mesoderm development
|
GO:2000380 |
4 |
0.138
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
93 |
0.137
|
|
|
|
heart process
|
GO:0003015 |
62 |
0.137
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
59 |
0.137
|
|
|
|
positive regulation of ossification
|
GO:0045778 |
32 |
0.135
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
65 |
0.134
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
41 |
0.133
|
|
|
|
regulation of cell cell adhesion
|
GO:0022407 |
57 |
0.133
|
|
|
|
muscle structure development
|
GO:0061061 |
98 |
0.133
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.132
|
|
|
|
retina homeostasis
|
GO:0001895 |
42 |
0.130
|
Human |
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
209 |
0.129
|
|
|
|
negative regulation of developmental process
|
GO:0051093 |
247 |
0.128
|
|
|
|
muscle system process
|
GO:0003012 |
81 |
0.128
|
|
|
|
actin filament based movement
|
GO:0030048 |
17 |
0.127
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.125
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.122
|
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
211 |
0.122
|
|
|
|
regulation of keratinocyte proliferation
|
GO:0010837 |
11 |
0.121
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
116 |
0.120
|
|
|
|
response to lipid
|
GO:0033993 |
206 |
0.119
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
404 |
0.119
|
|
|
|
apoptotic mitochondrial changes
|
GO:0008637 |
57 |
0.118
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
97 |
0.118
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
185 |
0.117
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.117
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.114
|
|
|
|
regulation of cardiac muscle tissue development
|
GO:0055024 |
13 |
0.114
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
132 |
0.113
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.112
|
|
|
|
negative regulation of cardiac muscle tissue development
|
GO:0055026 |
7 |
0.112
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
135 |
0.112
|
Human |
|
|
regulation of actin filament based process
|
GO:0032970 |
141 |
0.111
|
|
|
|
positive regulation of release of cytochrome c from mitochondria
|
GO:0090200 |
18 |
0.110
|
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
117 |
0.109
|
|
|
|
establishment of protein localization to membrane
|
GO:0090150 |
121 |
0.109
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.109
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
227 |
0.109
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.108
|
|
|
|
cardiac muscle cell action potential involved in contraction
|
GO:0086002 |
21 |
0.108
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.108
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
148 |
0.107
|
|
|
|
prostate gland development
|
GO:0030850 |
3 |
0.107
|
|
|
|
growth
|
GO:0040007 |
202 |
0.106
|
Zebrafish |
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.105
|
|
|
|
single organism membrane organization
|
GO:0044802 |
268 |
0.103
|
|
|
|
negative regulation of cellular component movement
|
GO:0051271 |
106 |
0.102
|
|
|
|
release of cytochrome c from mitochondria
|
GO:0001836 |
35 |
0.102
|
|
|
|
heart development
|
GO:0007507 |
95 |
0.102
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
127 |
0.102
|
|
|
|
cell cycle phase transition
|
GO:0044770 |
173 |
0.101
|
|
|
|
regulation of release of cytochrome c from mitochondria
|
GO:0090199 |
29 |
0.101
|
|
|
|
chromatin assembly or disassembly
|
GO:0006333 |
78 |
0.098
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
71 |
0.097
|
|
|
|
negative regulation of locomotion
|
GO:0040013 |
118 |
0.096
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
147 |
0.096
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
67 |
0.095
|
Human |
|
|
fatty acid derivative metabolic process
|
GO:1901568 |
35 |
0.095
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
106 |
0.094
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.094
|
|
|
|
copulation
|
GO:0007620 |
1 |
0.094
|
|
|
|
chromatin assembly
|
GO:0031497 |
61 |
0.094
|
|
|
|
endomembrane system organization
|
GO:0010256 |
196 |
0.094
|
|
|
|
regulation of cell cycle arrest
|
GO:0071156 |
36 |
0.093
|
|
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.093
|
|
|
|
cell development
|
GO:0048468 |
328 |
0.092
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.092
|
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
66 |
0.091
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.091
|
|
|
|
intermediate filament bundle assembly
|
GO:0045110 |
5 |
0.091
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
179 |
0.090
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
89 |
0.090
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.089
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
158 |
0.089
|
|
|
|
gtp catabolic process
|
GO:0006184 |
237 |
0.088
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.088
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
408 |
0.088
|
|
|
|
negative regulation of platelet aggregation
|
GO:0090331 |
3 |
0.086
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
166 |
0.086
|
|
|
|
negative regulation of cardiac muscle tissue growth
|
GO:0055022 |
2 |
0.086
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.086
|
|
|
|
insemination
|
GO:0007320 |
1 |
0.086
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
85 |
0.086
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
35 |
0.085
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
166 |
0.085
|
|
|
|
negative regulation of catagen
|
GO:0051796 |
1 |
0.085
|
|
|
|
regulation of gtpase activity
|
GO:0043087 |
180 |
0.084
|
|
|
|
regulation of epidermis development
|
GO:0045682 |
19 |
0.084
|
|
|
|
humoral immune response
|
GO:0006959 |
49 |
0.084
|
Human |
|
|
aging
|
GO:0007568 |
66 |
0.083
|
Human |
|
|
female genitalia development
|
GO:0030540 |
2 |
0.083
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
186 |
0.082
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.081
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
104 |
0.080
|
|
|
|
vasodilation
|
GO:0042311 |
4 |
0.080
|
|
|
|
mitochondrion organization
|
GO:0007005 |
156 |
0.080
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
281 |
0.079
|
|
|
|
cellular response to starvation
|
GO:0009267 |
58 |
0.079
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
72 |
0.079
|
|
|
|
response to endoplasmic reticulum stress
|
GO:0034976 |
49 |
0.077
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
75 |
0.077
|
|
|
|
post golgi vesicle mediated transport
|
GO:0006892 |
36 |
0.077
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.075
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.075
|
|
|
|
response to radiation
|
GO:0009314 |
151 |
0.075
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.074
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
207 |
0.074
|
|
|
|
tissue migration
|
GO:0090130 |
119 |
0.074
|
Human |
|
|
response to zinc ion
|
GO:0010043 |
12 |
0.073
|
|
|
|
regulation of mitochondrion organization
|
GO:0010821 |
54 |
0.073
|
|
|
|
cell growth
|
GO:0016049 |
160 |
0.072
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
45 |
0.072
|
|
|
|
negative regulation of growth
|
GO:0045926 |
97 |
0.071
|
|
|
|
hair follicle development
|
GO:0001942 |
11 |
0.071
|
Human |
|
|
mitotic cell cycle phase transition
|
GO:0044772 |
162 |
0.071
|
|
|
|
desmosome assembly
|
GO:0002159 |
4 |
0.071
|
|
|
|
cellular response to ionizing radiation
|
GO:0071479 |
32 |
0.071
|
|
|
|
heart contraction
|
GO:0060047 |
62 |
0.069
|
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.068
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
34 |
0.067
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
53 |
0.067
|
|
|
|
nucleotide excision repair
|
GO:0006289 |
31 |
0.067
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
189 |
0.067
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
205 |
0.066
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
113 |
0.066
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
239 |
0.066
|
|
|
|
autonomic nervous system development
|
GO:0048483 |
1 |
0.065
|
|
|
|
mating
|
GO:0007618 |
1 |
0.065
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
79 |
0.065
|
|
|
|
organelle assembly
|
GO:0070925 |
176 |
0.065
|
|
|
|
positive regulation of endothelial cell differentiation
|
GO:0045603 |
2 |
0.065
|
|
|
|
mapk cascade
|
GO:0000165 |
288 |
0.065
|
|
|
|
positive regulation of protein oligomerization
|
GO:0032461 |
17 |
0.064
|
|
|
|
replicative cell aging
|
GO:0001302 |
3 |
0.063
|
|
|
|
negative regulation of g1 s transition of mitotic cell cycle
|
GO:2000134 |
29 |
0.063
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
175 |
0.063
|
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043280 |
69 |
0.062
|
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
171 |
0.062
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
85 |
0.061
|
|
|
|
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress
|
GO:0070059 |
12 |
0.061
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
126 |
0.061
|
|
|
|
cell activation
|
GO:0001775 |
213 |
0.061
|
Human |
|
|
negative regulation of cell adhesion
|
GO:0007162 |
64 |
0.060
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
73 |
0.060
|
|
|
|
cellular response to decreased oxygen levels
|
GO:0036294 |
51 |
0.059
|
|
|
|
regulation of heart rate by cardiac conduction
|
GO:0086091 |
19 |
0.059
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
185 |
0.058
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
128 |
0.058
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.058
|
|
|
|
negative regulation of mesoderm development
|
GO:2000381 |
2 |
0.057
|
|
|
|
positive regulation of insulin like growth factor receptor signaling pathway
|
GO:0043568 |
4 |
0.057
|
|
|
|
signal transduction in response to dna damage
|
GO:0042770 |
57 |
0.057
|
|
|
|
positive regulation of transport
|
GO:0051050 |
336 |
0.057
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage by p53 class mediator
|
GO:0042771 |
23 |
0.056
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
181 |
0.056
|
|
|
|
dna damage checkpoint
|
GO:0000077 |
68 |
0.056
|
|
|
|
response to inorganic substance
|
GO:0010035 |
127 |
0.056
|
|
|
|
response to oxidative stress
|
GO:0006979 |
121 |
0.056
|
|
|
|
blood circulation
|
GO:0008015 |
113 |
0.055
|
|
|
|
immune response
|
GO:0006955 |
307 |
0.055
|
Human |
|
|
cell cell junction organization
|
GO:0045216 |
69 |
0.055
|
|
|
|
arachidonic acid metabolic process
|
GO:0019369 |
14 |
0.055
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
73 |
0.055
|
|
|
|
dna conformation change
|
GO:0071103 |
113 |
0.054
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
207 |
0.054
|
|
|
|
plasma membrane organization
|
GO:0007009 |
115 |
0.054
|
|
|
|
response to oxygen levels
|
GO:0070482 |
100 |
0.054
|
|
|
|
negative regulation of cell growth
|
GO:0030308 |
83 |
0.053
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
177 |
0.053
|
|
|
|
er nucleus signaling pathway
|
GO:0006984 |
23 |
0.052
|
|
|
|
response to hypoxia
|
GO:0001666 |
96 |
0.052
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.052
|
|
|
|
regulation of small gtpase mediated signal transduction
|
GO:0051056 |
156 |
0.051
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
3 |
0.051
|
|
|
|
molting cycle process
|
GO:0022404 |
12 |
0.051
|
Human |
|
|
negative regulation of cell cycle process
|
GO:0010948 |
121 |
0.051
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.051
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
172 |
0.051
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
111 |
0.051
|
|
|
|
complement activation
|
GO:0006956 |
19 |
0.051
|
Human |
|
|
lipoxin a4 metabolic process
|
GO:2001302 |
1 |
0.051
|
|
|
|
positive regulation of cellular component movement
|
GO:0051272 |
181 |
0.050
|
|
|
|
protein oligomerization
|
GO:0051259 |
173 |
0.050
|
|
|
|
positive regulation of cytokinesis
|
GO:0032467 |
29 |
0.050
|
|
|
|
positive regulation of mitochondrion organization
|
GO:0010822 |
30 |
0.050
|
|
|
|
cell cycle checkpoint
|
GO:0000075 |
117 |
0.050
|
|
|
|
negative regulation of homotypic cell cell adhesion
|
GO:0034111 |
3 |
0.049
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
262 |
0.049
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
115 |
0.049
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.049
|
|
|
|
dna packaging
|
GO:0006323 |
77 |
0.049
|
|
|
|
action potential
|
GO:0001508 |
34 |
0.049
|
|
|
|
glial cell apoptotic process
|
GO:0034349 |
7 |
0.049
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.048
|
|
|
|
muscle organ development
|
GO:0007517 |
56 |
0.048
|
|
|
|
response to estrogen
|
GO:0043627 |
47 |
0.048
|
|
|
|
regulation of system process
|
GO:0044057 |
101 |
0.047
|
|
|
|
positive regulation of vasodilation
|
GO:0045909 |
4 |
0.047
|
|
|
|
protein processing
|
GO:0016485 |
226 |
0.047
|
|
|
|
signal transduction by phosphorylation
|
GO:0023014 |
297 |
0.047
|
|
|
|
negative regulation of epithelial cell differentiation
|
GO:0030857 |
6 |
0.047
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.047
|
|
|
|
protein homooligomerization
|
GO:0051260 |
100 |
0.047
|
|
|
|
cytokine production
|
GO:0001816 |
247 |
0.046
|
|
|
|
cellular response to radiation
|
GO:0071478 |
65 |
0.046
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.046
|
|
|
|
cell cycle arrest
|
GO:0007050 |
71 |
0.046
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
68 |
0.046
|
|
|
|
fatty acid biosynthetic process
|
GO:0006633 |
46 |
0.045
|
|
|
|
positive regulation of cell substrate adhesion
|
GO:0010811 |
37 |
0.045
|
|
|
|
regulation of platelet aggregation
|
GO:0090330 |
4 |
0.045
|
|
|
|
positive regulation of rho gtpase activity
|
GO:0032321 |
56 |
0.045
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
59 |
0.045
|
|
|
|
positive regulation of locomotion
|
GO:0040017 |
186 |
0.045
|
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.045
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
59 |
0.045
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
34 |
0.045
|
|
|
|
regulation of growth
|
GO:0040008 |
165 |
0.045
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
84 |
0.045
|
|
|
|
striated muscle contraction
|
GO:0006941 |
52 |
0.045
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
88 |
0.044
|
|
|
|
cell junction organization
|
GO:0034330 |
79 |
0.044
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
190 |
0.044
|
|
|
|
positive regulation of cysteine type endopeptidase activity
|
GO:2001056 |
79 |
0.044
|
|
|
|
regulation of cellular senescence
|
GO:2000772 |
13 |
0.044
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
140 |
0.043
|
|
|
|
positive regulation of cell cycle arrest
|
GO:0071158 |
23 |
0.043
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
242 |
0.043
|
|
|
|
defense response
|
GO:0006952 |
315 |
0.043
|
Human |
|
|
g1 dna damage checkpoint
|
GO:0044783 |
18 |
0.043
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
63 |
0.043
|
|
|
|
response to cytokine
|
GO:0034097 |
232 |
0.043
|
|
|
|
ion homeostasis
|
GO:0050801 |
230 |
0.043
|
|
|
|
angiogenesis
|
GO:0001525 |
147 |
0.043
|
|
|
|
long chain fatty acid biosynthetic process
|
GO:0042759 |
4 |
0.042
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.042
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.042
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
185 |
0.042
|
|
|
|
chromatin modification
|
GO:0016568 |
298 |
0.042
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.041
|
|
|
|
regulation of response to external stimulus
|
GO:0032101 |
222 |
0.041
|
|
|
|
golgi vesicle transport
|
GO:0048193 |
80 |
0.041
|
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
394 |
0.041
|
|
|
|
chromatin organization
|
GO:0006325 |
351 |
0.040
|
|
|
|
cellular response to drug
|
GO:0035690 |
27 |
0.040
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
156 |
0.040
|
|
|
|
cellular response to metal ion
|
GO:0071248 |
43 |
0.040
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.039
|
|
|
|
cell junction assembly
|
GO:0034329 |
67 |
0.039
|
|
|
|
protein homotetramerization
|
GO:0051289 |
28 |
0.039
|
|
|
|
dna repair
|
GO:0006281 |
198 |
0.039
|
|
|
|
icosanoid metabolic process
|
GO:0006690 |
35 |
0.039
|
|
|
|
positive regulation of odontogenesis
|
GO:0042482 |
3 |
0.039
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
69 |
0.039
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
102 |
0.038
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
72 |
0.038
|
|
|
|
mitotic cell cycle checkpoint
|
GO:0007093 |
68 |
0.038
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
24 |
0.038
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.038
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
118 |
0.038
|
|
|
|
ossification
|
GO:0001503 |
121 |
0.038
|
|
|
|
pulmonary valve formation
|
GO:0003193 |
1 |
0.038
|
|
|
|
lipid modification
|
GO:0030258 |
84 |
0.038
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
45 |
0.038
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.037
|
|
|
|
regulation of cardiac muscle cell contraction
|
GO:0086004 |
23 |
0.037
|
|
|
|
gtp metabolic process
|
GO:0046039 |
239 |
0.037
|
|
|
|
oxidation reduction process
|
GO:0055114 |
396 |
0.037
|
|
|
|
striated muscle cell proliferation
|
GO:0014855 |
7 |
0.037
|
|
|
|
cardiac muscle cell cardiac muscle cell adhesion
|
GO:0086042 |
1 |
0.037
|
|
|
|
g protein coupled receptor signaling pathway coupled to cyclic nucleotide second messenger
|
GO:0007187 |
43 |
0.036
|
|
|
|
protein targeting
|
GO:0006605 |
187 |
0.036
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
96 |
0.036
|
|
|
|
cellular senescence
|
GO:0090398 |
34 |
0.036
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.036
|
|
|
|
cell aging
|
GO:0007569 |
52 |
0.035
|
|
|
|
regeneration
|
GO:0031099 |
4 |
0.035
|
Zebrafish |
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.035
|
|
|
|
tissue homeostasis
|
GO:0001894 |
63 |
0.035
|
Human |
|
|
dna damage response signal transduction by p53 class mediator resulting in transcription of p21 class mediator
|
GO:0006978 |
11 |
0.035
|
|
|
|
unsaturated fatty acid biosynthetic process
|
GO:0006636 |
21 |
0.035
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
166 |
0.035
|
|
|
|
neuron death
|
GO:0070997 |
65 |
0.034
|
|
|
|
cellular response to hypoxia
|
GO:0071456 |
51 |
0.034
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
78 |
0.034
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
157 |
0.034
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.034
|
|
|
|
secretion by cell
|
GO:0032940 |
226 |
0.034
|
|
|
|
zymogen activation
|
GO:0031638 |
70 |
0.034
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.034
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
205 |
0.033
|
|
|
|
regulation of striated muscle contraction
|
GO:0006942 |
37 |
0.033
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
39 |
0.033
|
|
|
|
innate immune response
|
GO:0045087 |
178 |
0.033
|
Human |
|
|
cardiac muscle tissue development
|
GO:0048738 |
39 |
0.033
|
|
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.033
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
166 |
0.033
|
|
|
|
regulation of cell cycle g1 s phase transition
|
GO:1902806 |
42 |
0.032
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.032
|
|
|
|
regulation of protein transport
|
GO:0051223 |
213 |
0.032
|
|
|
|
somatic stem cell division
|
GO:0048103 |
1 |
0.032
|
|
|
|
limb morphogenesis
|
GO:0035108 |
16 |
0.032
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
67 |
0.032
|
|
|
|
mitotic dna damage checkpoint
|
GO:0044773 |
28 |
0.032
|
|
|
|
smooth muscle tissue development
|
GO:0048745 |
3 |
0.032
|
|
|
|
regulation of protein stability
|
GO:0031647 |
87 |
0.032
|
|
|
|
regulation of fibroblast apoptotic process
|
GO:2000269 |
8 |
0.032
|
|
|
|
homotypic cell cell adhesion
|
GO:0034109 |
47 |
0.031
|
|
|
|
cardiac conduction
|
GO:0061337 |
23 |
0.031
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
92 |
0.031
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
121 |
0.031
|
|
|
|
response to starvation
|
GO:0042594 |
59 |
0.031
|
|
|
|
platelet aggregation
|
GO:0070527 |
32 |
0.031
|
|
|
|
protein stabilization
|
GO:0050821 |
64 |
0.031
|
|
|
|
neuron differentiation
|
GO:0030182 |
138 |
0.030
|
|
|
|
regulation of fibroblast proliferation
|
GO:0048145 |
32 |
0.030
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
230 |
0.030
|
|
|
|
positive regulation of cell division
|
GO:0051781 |
59 |
0.030
|
|
|
|
protein tetramerization
|
GO:0051262 |
47 |
0.030
|
|
|
|
locomotory behavior
|
GO:0007626 |
1 |
0.030
|
|
|
|
cell communication involved in cardiac conduction
|
GO:0086065 |
18 |
0.030
|
|
|
|
mitotic g1 dna damage checkpoint
|
GO:0031571 |
17 |
0.030
|
|
|
|
regulation of protein processing
|
GO:0070613 |
150 |
0.030
|
|
|
|
dna damage response signal transduction by p53 class mediator
|
GO:0030330 |
44 |
0.030
|
|
|
|
cellular response to calcium ion
|
GO:0071277 |
19 |
0.030
|
|
|
|
negative regulation of cell cycle g1 s phase transition
|
GO:1902807 |
29 |
0.030
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
155 |
0.029
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
232 |
0.029
|
|
|
|
regulation of epidermal cell differentiation
|
GO:0045604 |
15 |
0.029
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
117 |
0.029
|
|
|
|
cellular response to lipid
|
GO:0071396 |
127 |
0.029
|
|
|
|
cardiac muscle cell proliferation
|
GO:0060038 |
6 |
0.028
|
|
|
|
central nervous system development
|
GO:0007417 |
123 |
0.028
|
|
|
|
positive regulation of mitochondrial depolarization
|
GO:0051901 |
3 |
0.028
|
|
|
|
complement activation lectin pathway
|
GO:0001867 |
7 |
0.028
|
Human |
|
|
lipid biosynthetic process
|
GO:0008610 |
177 |
0.028
|
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.028
|
|
|
|
regulation of vasodilation
|
GO:0042312 |
4 |
0.028
|
|
|
|
cellular response to oxygen levels
|
GO:0071453 |
55 |
0.028
|
|
|
|
dna integrity checkpoint
|
GO:0031570 |
71 |
0.028
|
|
|
|
av node cell to bundle of his cell communication by electrical coupling
|
GO:0086053 |
1 |
0.028
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
172 |
0.028
|
|
|
|
glandular epithelial cell differentiation
|
GO:0002067 |
6 |
0.028
|
|
|
|
regulation of ossification
|
GO:0030278 |
58 |
0.028
|
|
|
|
cannabinoid signaling pathway
|
GO:0038171 |
2 |
0.027
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.027
|
|
|
|
muscle cell development
|
GO:0055001 |
29 |
0.027
|
|
|
|
skeletal system development
|
GO:0001501 |
79 |
0.027
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
50 |
0.027
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
97 |
0.027
|
|
|
|
epithelium migration
|
GO:0090132 |
119 |
0.027
|
Human |
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
303 |
0.027
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
116 |
0.027
|
|
|
|
striated muscle cell differentiation
|
GO:0051146 |
43 |
0.027
|
|
|
|
melanin metabolic process
|
GO:0006582 |
1 |
0.027
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
71 |
0.027
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
80 |
0.027
|
|
|
|
positive regulation of immune system process
|
GO:0002684 |
283 |
0.027
|
Human |
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
75 |
0.026
|
|
|
|
muscle contraction
|
GO:0006936 |
73 |
0.026
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.026
|
|
|
|
intrinsic apoptotic signaling pathway by p53 class mediator
|
GO:0072332 |
37 |
0.026
|
|
|
|
response to calcium ion
|
GO:0051592 |
46 |
0.026
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
50 |
0.026
|
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.026
|
|
|
|
digestive system development
|
GO:0055123 |
75 |
0.026
|
|
|
|
positive regulation of protein complex assembly
|
GO:0031334 |
86 |
0.026
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
177 |
0.025
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
231 |
0.025
|
|
|
|
golgi to plasma membrane transport
|
GO:0006893 |
21 |
0.025
|
|
|
|
renal system development
|
GO:0072001 |
63 |
0.025
|
|
|
|
tube development
|
GO:0035295 |
125 |
0.025
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.025
|
|
|
|
regulation of heart rate
|
GO:0002027 |
38 |
0.025
|
|
|
|
regulation of muscle organ development
|
GO:0048634 |
27 |
0.025
|
|
